ArticleCell death & disease2024

Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma.

Feng Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.